HIV is AGT's first clinical trial
AGT103-T, our HIV therapeutic, is currently in phase I clinical trials. This is our first clinical trial, however, AGT has conducted numerous pre-clinical trials in animal models as proofs of concept. Additionally, one of our studies has been replicated by NIAID. Information about our pre-clinical success, coordinated research, and ongoing clinical trial can all be found on our website.